"Despite induction failure being 3-times more common in T-ALL than B-ALL, little was known about risk factors, optimum treatment, and the genomic landscape. If we can gain more understanding, we hope ...
An education session at the 2022 European Hematology Association Congress featured updates on using genetic and immune characteristics to select the optimal treatment pathway in chronic lymphocytic ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback